← Leaderboards
Deepak Nagrath
University Of Michigan At Ann Arbor
$8,423,772
Attributed
$17,496,489
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,496,489 · 8
By mechanism
R01$17,496,489 · 8
Top collaborators
- Xiongbin Lu5 shared
- Samuel C Mok5 shared
- Anil K Sood5 shared
- Theodore S Lawrence4 shared
- James J. Moon4 shared
- Sunitha Nagrath4 shared
- Alejandro Soto-Gutierrez4 shared
- Benita Tamrazi4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Hayley Sarah McLoughlin$3,898,382
- Vasantha Padmanabhan$19,995,903
- Theodore S Lawrence$30,022,406
- Alexandre Dasilva$11,229,322
- Derek Dang$76,692
Others in their field
Other Emerging Leaders on “Metabolic”
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Rainer Lohmann · University Of Rhode Island$14,400,221
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
MetabolicMediatingIn VitroMetabolismCellsIn VivoMalignant NeoplasmsTumorPublic HealthRegulationIsotopesBaseSourceDesignLeadPathway InteractionsCommunicationRecurrenceCitric Acid CycleProductionCell ProliferationNew Therapeutic TargetFibroblastsNutrient
Grant awards (32)
New methods to measure and interrupt metabolic fluxes in brain cancer$2,820,337
R01 · FY2025 · CA
Biomaterials for modulating the gut microbiome for immune activation$607,815
R01 · FY2025 · CA
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$596,380
R01 · FY2025 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$574,113
R01 · FY2025 · CA · contact PI
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$567,330
R01 · FY2024 · CA
Biomaterials for modulating the gut microbiome for immune activation$542,526
R01 · FY2024 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$534,216
R01 · FY2024 · CA · contact PI
Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy$506,236
R01 · FY2024 · DK
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$585,078
R01 · FY2023 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$579,715
R01 · FY2023 · CA · contact PI
Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy$527,329
R01 · FY2023 · DK
Biomaterials for modulating the gut microbiome for immune activation$483,524
R01 · FY2023 · CA
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas$610,986
R01 · FY2022 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors$581,396
R01 · FY2022 · CA · contact PI
Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy$526,476
R01 · FY2022 · DK
Biomaterials for modulating the gut microbiome for immune activation$493,392
R01 · FY2022 · CA
Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer$462,390
R01 · FY2022 · CA · contact PI
Identification of USP13 as a therapeutic target for ovarian cancer$347,513
R01 · FY2022 · CA
Mini-Livers Derived from Human IPS Cells for Modeling Steatosis and Therapy$536,333
R01 · FY2021 · DK
Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer$471,827
R01 · FY2021 · CA · contact PI
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism$398,769
R01 · FY2021 · CA · contact PI
Identification of USP13 as a therapeutic target for ovarian cancer$357,498
R01 · FY2021 · CA
Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer$471,827
R01 · FY2020 · CA · contact PI
Identification of USP13 as a therapeutic target for ovarian cancer$360,271
R01 · FY2020 · CA
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism$316,861
R01 · FY2020 · CA · contact PI
Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer$457,671
R01 · FY2019 · CA · contact PI
Identification of USP13 as a therapeutic target for ovarian cancer$352,044
R01 · FY2019 · CA
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism$308,362
R01 · FY2019 · CA · contact PI
Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer$485,829
R01 · FY2018 · CA · contact PI
Identification of USP13 as a therapeutic target for ovarian cancer$379,129
R01 · FY2018 · CA
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism$320,959
R01 · FY2018 · CA · contact PI
Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism$332,357
R01 · FY2017 · CA · contact PI